US 12171832
Methods of treating ulcerative colitis
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12171832 (Methods of treating ulcerative colitis) held by Takeda Pharmaceutical Company Limited expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/395